Research Articles | Page 67 | Aplastic Anemia and MDS International Foundation

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Titlesort descending Original Publication Date Journal Bone Marrow Disease
Searching for a Light at the End of the Tunnel? Beyond Hypomethylating Agents in Myelodysplastic Syndromes Jun 2016 Am Soc Clin Oncol Educ Book myelodysplastic syndromes (MDS)
Searching for a Light at the End of the Tunnel? Beyond Hypomethylating Agents in Myelodysplastic Syndromes. Jan 2017 Am Soc Clin Oncol Educ Book myelodysplastic syndromes (MDS)
Second allogeneic hematopoietic stem cell transplantation in children with severe aplastic anemia Jun 2015 Bone Marrow Transplant aplastic anemia
Selective splenic artery embolization for the treatment of thrombocytopenia and hypersplenism in paroxysmal nocturnal hemoglobinuria Mar 2014 J Hematol Oncol paroxysmal nocturnal hemoglobinuria (PNH)
Selectivity of C3-opsonin targeted complement inhibitors: A distinct advantage in the protection of erythrocytes from paroxysmal nocturnal hemoglobinuria patients Jan 2016 Immunobiology paroxysmal nocturnal hemoglobinuria (PNH)
Self-perception of symptoms of anemia and fatigue before and after blood transfusions in patients with myelodysplastic syndromes Nov 2014 Eur J Oncol Nurs myelodysplastic syndromes (MDS)
Self-reported sleep disturbance and survival in myelodysplastic syndromes Mar 2017 Br J Haematol myelodysplastic syndromes (MDS)
Sequential combination of azacitidine and lenalidomide in del(5q) higher-risk myelodysplastic syndromes or acute myeloid leukemia: a phase I study Jan 2013 Leukemia myelodysplastic syndromes (MDS)
Serial assessment of suspected myelodysplastic syndromes: significance of flow cytometric findings validated by cytomorphology, cytogenetics, and molecular genetics Aug 2012 Haematologica myelodysplastic syndromes (MDS)
Serologic response to meningococcal vaccination in patients with paroxysmal nocturnal hemoglobinuria (PNH) chronically treated with the terminal complement inhibitor eculizumab Jan 2017 Ann Hematol paroxysmal nocturnal hemoglobinuria (PNH)